AU2002213145A1 - Detection and quantification of human herpes viruses - Google Patents

Detection and quantification of human herpes viruses

Info

Publication number
AU2002213145A1
AU2002213145A1 AU2002213145A AU1314502A AU2002213145A1 AU 2002213145 A1 AU2002213145 A1 AU 2002213145A1 AU 2002213145 A AU2002213145 A AU 2002213145A AU 1314502 A AU1314502 A AU 1314502A AU 2002213145 A1 AU2002213145 A1 AU 2002213145A1
Authority
AU
Australia
Prior art keywords
quantification
detection
herpes viruses
human herpes
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213145A
Inventor
Robert B. Harris
Thomas R. Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vigen Laboratories Inc
Original Assignee
Vigen Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vigen Laboratories Inc filed Critical Vigen Laboratories Inc
Publication of AU2002213145A1 publication Critical patent/AU2002213145A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Signal Processing (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002213145A 2000-10-24 2001-10-12 Detection and quantification of human herpes viruses Abandoned AU2002213145A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24290300P 2000-10-24 2000-10-24
US60/242,903 2000-10-24
PCT/US2001/031892 WO2002034953A2 (en) 2000-10-24 2001-10-12 Detection and quantification of human herpes viruses

Publications (1)

Publication Number Publication Date
AU2002213145A1 true AU2002213145A1 (en) 2002-05-06

Family

ID=22916590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213145A Abandoned AU2002213145A1 (en) 2000-10-24 2001-10-12 Detection and quantification of human herpes viruses

Country Status (4)

Country Link
US (1) US7338761B2 (en)
EP (1) EP1432832A2 (en)
AU (1) AU2002213145A1 (en)
WO (1) WO2002034953A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100460747B1 (en) * 2002-09-09 2004-12-08 주식회사 바이오메드랩 PROBE FOR DETECTING Human herpesvirus, GENOTYPING KIT AND GENOTYPING METHOD FOR Human herpes virus USING THE SAME
US7291488B2 (en) * 2003-04-25 2007-11-06 Becton, Dickinson & Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
US20060252032A1 (en) * 2005-01-28 2006-11-09 Third Wave Technologies, Inc. Detection of human herpesviruses
RU2348695C2 (en) 2006-05-23 2009-03-10 Закрытое акционерное общество "Молекулярно-медицинские технологии" Differentiating and specific oligonucleotids for dna sequence identification for infection agents in biological materials, method of species identification of infection agents, biochip and method implementation kit
EP2813849A1 (en) * 2013-06-10 2014-12-17 Charité-Universitätsmedizin Berlin (Charité) EBV-specific immune signature as diagnostic markers in Chronic Fatigue Syndrome (CFS)

Also Published As

Publication number Publication date
US20040072147A1 (en) 2004-04-15
EP1432832A2 (en) 2004-06-30
US7338761B2 (en) 2008-03-04
WO2002034953A3 (en) 2004-04-15
WO2002034953A2 (en) 2002-05-02
WO2002034953A9 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AUPP974599A0 (en) Detection and classification of breathing patterns
AU2001271998A1 (en) Detection and treatment of polycystic kidney disease
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2003220188A1 (en) Detection and quantification of modified proteins
AU2002314466A1 (en) Withasol and methods of use
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001296864A1 (en) Detection of varicella-zoster virus
AU2001267428A1 (en) Direct detection of individual molecules
AU2001239846A1 (en) Dsp with dual-mac processor and dual-mac coprocessor
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2001247196A1 (en) Methods and compositions for detection of disease
AU2002213145A1 (en) Detection and quantification of human herpes viruses
AU3454899A (en) Methods of separation and detection
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001212172A1 (en) Flavivirus detection and quantification assay
GB0018050D0 (en) Detection of human papillomavirus mRNA
AU2000239273A1 (en) Systems and methods of viral marketing
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2002233988A1 (en) Assay for the detection and quantitation of hemimethylation
AU2001268236A1 (en) Use of aicar and related compounds
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2960000A (en) Detection of human immunodeficiency virus
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof